As Americans nationwide turn to GLP-1 medications to lose weight, some are unaware of off-label side effects, according to a Sept. 4 CBS News report.
Novo Nordisk faces lawsuit following slew of Ozempic-related GI side effects
As Americans nationwide turn to GLP-1 medications to lose weight, some are unaware of off-label side effects, according to a Sept. 4 CBS News report.